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ORIGINAL ARTICLE
Prenatal diagnosis of congenital heart disease
(CHD) based on fetal echocardiography is used
in many countries impacting both the prevalence
and type of CHD, as many of these affected preg-
nancies are subsequently terminated.1–6 Much 
of the literature regarding the outcome for CHD
diagnosed in utero relates to Western countries
and an ethnicity-dependent difference in its post-
natal detection has been well documented rela-
tive to analogous Eastern populations.7 Further,
prenatal detection is more likely in cases involv-
ing severe, complex cardiac lesions, with a high
incidence of associated prenatal loss and the
spectrum of prenatal CHD differs from that seen
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postnatally.4,8,9 Outcome and clinical features
for CHDs diagnosed in utero are important both
for prenatal counseling and perinatal manage-
ment. In this retrospective study, therefore, we
have attempted to establish the clinical features
and outcome for fetal CHD in a Taiwanese terti-
ary care medical center to determine the ethnic
variation.
Materials and Methods
A total of 339 fetal patients, referred for fetal
echocardiographic examination and who were
delivered at National Taiwan University Hospital
between January 1995 and December 2000, were
enrolled in this retrospective study. Fetal echocar-
diography was performed using two-dimensional
pulsed Doppler (Sonolayer 270A®; Toshiba, Tokyo,
Japan). Where indicated, color Doppler (XP120;
Acuson, Mountain View, CA, USA) was also used
for homodynamic assessment. A pediatric cardi-
ologist examined most of the enrolled fetuses.
Segmental analysis for cardiac situs, pulmonary
venous return, atrial and ventricular chambers,
cardiac valves, ventriculo-arterial connections and
aortic and ductal arches were performed in all
the cases. Echocardiography, angiography, ultra-
fast computed tomography, surgery and/or au-
topsy were utilized for postnatal diagnosis.
Data with respect to the indications for fetal
echocardiography, maternal age, gravida, para,
prenatal diagnosis, chromosomal and extracardiac
anomalies, postnatal diagnosis and outcome were
obtained by reviewing the medical records.
STATA software version 7.0 (Stata Corp., College
Station, TX, USA) was used for statistical analysis
based on χ2 and Fisher’s exact tests. Kaplan and
Meier nonparametric estimation was used to
generate survival curves.10
Results
Of the 726 fetuses examined using fetal echocar-
diography, 387 who were subsequently delivered
at other hospitals were excluded from this study.
Of the remaining 339 fetuses delivered at our 
institution, 103 had cardiac abnormalities. The
outcomes for the study population are depicted
in Figure 1. The reasons for the referral and sub-
sequent findings are presented in Table 1. Of the
124 cases referred by the obstetrician because of
suspected fetal CHD, the diagnosis was confirmed
in 79 (63.7%). The most common indication for
referral was abnormal appearance of the heart on
ultrasound, as noted by the obstetrician (36.6%)
and family history of CHD (25.7%). Structural
heart defects were diagnosed in three fetuses
(3.4%) scanned because of family history of CHD
as follows: tuberous sclerosis in the mother and
one sibling of a fetus with cardiac rhabdomy-
oma; a right atrial isomerism in a sibling also
identified in an enrolled fetus; and aortic steno-
sis diagnosed in the mother of a neonate with 
a postnatally detected ostium secundum defect.
Of the 103 cases of CHD, 42 (40.8%) had
survived after follow-ups ranging from 1 week to
6 years. The type of heart defect and outcome for
the affected fetuses are summarized in Table 2.
Thirty fetuses (29.1%) were terminated, with only
three (2.9%) expiring in utero. Fifteen neonates
(14.6%) died during the neonatal stage. Eleven
children (10.7%) expired in infancy, two (1.9%)
with right atrial isomerism at the age of 1 year.
Gestational age at diagnosis ranged from 17 to
40 weeks (mean, 27.8) and diagnosis was made
before 24 weeks in 37 cases (35.9%), with 25 of
these pregnancies subsequently terminated.
Chromosomal or extracardiac abnormalities
were present in 25 (24%) fetuses (five had both).
Cytogenetic analysis was conducted for 53 fetuses,
with chromosomal abnormality detected in 15
cases (28.3%): trisomy 21 (n = 5); trisomy 18 (n =
3); and trisomy 13, mosaic trisomy 12, t(1;2)
(p34.1;q27), 6p duplication, 10q25 deletion,
18p-, and 22q11 microdeletion (n = 1 each). Five
pregnancies involving chromosomal abnormal-
ity were terminated. Death was the outcome 
in six of the 10 continued pregnancies, occurring
in utero (n = 1), neonatally (n = 4), and in infancy/
childhood (n = 1).
Omitting the minor extracardiac anomalies
(i.e. those without serious medical or cosmetic
sequelae), 15 (14.6%) of the CHD cases involv-
ed concomitant major extracardiac structural 
abnormalities. Of these, five were multiple extra-
cardiac anomalies. Major extracardiac anomalies
consisted of lesions of the central nervous system
(n = 6), genitourinary (n = 6), respiratory (n = 3),
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Figure 1. Outcomes for fetuses diagnosed with heart disease in utero. TOP = termination of pregnancy; IUD = intrauterine
death; NND = neonatal death; Inf/ChD = death in infancy or childhood; A = alive.
Table 1. Indications for fetal echocardiography
Indication
Enrolled CHD in enrolled Excluded Prenatally detected CHD
fetuses fetuses fetuses in excluded fetuses
Family history
Previous child 73 2 112 3
Maternal 12 1 1 1
Paternal 2 0 1 0
Maternal diabetes 2 0 0 0
Drug exposure 1 1 2 0
Collagen–vascular disease 1 0 0 0
Arrhythmia 36 4 35 0
Extracardiac and/or chromosomal 51 15 49 14
anomalies
Abnormal appearance of the heart 124 79 117 75
Miscellaneous 37 1 70 0
Total 339 103 387 93
CHD = congenital heart disease.
gastrointestinal (n = 3) and skeletal systems (n = 2),
and cleft lip and palate (n = 1). Except for five 
fetuses with coexisting chromosomal anomalies,
four with concomitant extracardiac anomalies
were terminated (Table 3). Three of the six con-
tinued pregnancies resulted in death of the fetus
either in utero (n = 1) or neonatally (n = 2). Of the
continued pregnancies, the overall mortality rate
was high for both groups of extracardiac (normal
karyotype; 3/6, 50%) and chromosomal anom-
alies (6/10, 60%).
Mortality rate was high in cases with isomerism,
double-outlet right ventricle and hypoplastic left
heart syndrome (64.3%, 57.1% and 100%, re-
spectively). Survival curves for dominant types of
CHD are presented in Figure 2, with interventions
and outcomes summarized below. Systemic-to-
pulmonary shunts were installed in eight patients
with right isomerism (modified and standard
Blalock–Taussig or Glenn), with four of these 
expiring. Four patients with right isomerism un-
derwent other surgical procedures including
S.M. Hsiao, et al
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Table 2. Outcome for fetuses with CHD
Diagnosis CA NK EA TOP IUD NND Inf/ChD A Op
Atrial isomerism 23 0 13 3 9 1 3 5 5 12
Hypoplastic left heart syndrome 12 1 5 1 3 0 4 4 0 6
Tetralogy of Fallot 11 4 2 2 3 0 2 0 6 6
Double-outlet right ventricle 11 3 6 2 4 1 1 2 3 5
Pulmonary stenosis/atresia 7 0 1 0 0 1 0 0 6 6
Ventricular septal defect 7 2 2 3 2 0 2 1 2 0
Complete transposition 4 0 2 0 2 0 0 0 2 2
Tricuspid dysplasia/Ebstein’s anomaly 4 1 1 0 1 0 2 0 1 0
Atrial septal defect 4 1 1 1 2 0 0 0 2 1
Tumor 4 0 0 0 1 0 0 0 3 1
Atrioventricular septal defect 3 3 0 0 2 0 0 0 1 1
Dilated cardiomegaly 3 0 1 1 0 0 0 0 3 0
Double-inlet ventricle 2 0 1 0 1 0 0 0 1 1
Tricuspid atresia 2 0 1 0 0 0 1 0 1 1
Congenital corrected transposition 2 0 0 0 0 0 0 0 2 1
Coarctation 1 0 0 1 0 0 0 0 1 0
Absent pulmonary valve 1 0 0 0 0 0 0 0 1 0
Hypertrophic cardiomegaly 1 0 0 0 0 0 0 1 0 0
Dextrocardia 1 0 1 1 0 0 0 0 1 0
Interrupted aortic arch 1 0 1 0 0 0 0 0 1 1
Total 103 15 38 15 30 3 15 13 42 44
CA = chromosomal anomaly; NK = normal karyotype; EA = extracardiac anomaly; TOP = termination of pregnancy; IUD = intrauterine death; NND =
neonatal death; Inf/ChD = death in infancy or childhood; A = alive; Op = operated.
Table 3. Incidence of associated extracardiac and chromosomal anomalies in CHD (n = 103) and 
outcome groups
Total
TOP (n = 30) IUD (n = 3) NND (n = 15) Inf/ChD (n = 43) A (n = 42 )
n (%) n (%) n (%) n (%) n (%)
Extracardiac anomalies 10 (10) 4 (13) 1 (33) 2 (13) 0 (0) 3 (7)
(normal karyotype)
Chromosomal anomalies 15 (15) 5 (17) 1 (33) 4 (27) 1 (2) 4 (10)
TOP = termination of pregnancy; IUD = intrauterine death; NND = neonatal death; Inf/ChD = death in infancy or childhood; A = alive.
coarctation repair (n = 2), total correction (n = 1)
and total anomalous pulmonary venous connec-
tion repair (n = 1), with three of these not surviv-
ing. All six patients with hypoplastic left heart
syndrome underwent Norwood operation (n = 3)
and coarctation repair (n = 3), however, all expired.
In contrast, all six patients with tetralogy of Fallot
underwent total correction and survived. Three of
the five patients with double-outlet right ventricle
who underwent Blalock–Taussig shunt (n = 2),
pulmonary artery banding (n = 1), pulmonary 
artery banding and coarctation repair (n = 1) and
complete repair (n = 1) expired. Six patients with
critical pulmonary stenosis/pulmonary atresia who
underwent balloon valvuloplasty (n = 4) and trans-
catheter valvotomy (n = 2) survived.
Cardiac arrhythmias was detected in 25 fe-
tuses of the sample (Table 4), five of whom had
coexisting cardiac defects: long QT syndrome with
perimembranous ventricular septal defect; atrial
bigeminy with critical pulmonary stenosis (n = 1);
paroxysmal supraventricular tachycardia with right
atrial isomerism (n = 1); and complete atrioven-
tricular (AV) block with postnatally detected atrial
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Figure 2. Postnatal survival curves for prenatally detected congenital heart disease. PS/PA = pulmonary stenosis/
pulmonary atresia; TOF = tetralogy of Fallot; VSD = ventricular septal defect; RAI = right atrial isomerism; DORV = double-
outlet right ventricle; HLHS = hypoplastic left heart syndrome.
Table 4. Outcome for fetuses with cardiac arrhythmia
Type of arrhythmia DU DP P SHD TOP IUD NND Inf/ChD A
Premature atrial contractions 11 0 0 0 1 0 0 0 0 11
Complete AV block 4 1 2 2 1 2 0 0 0 2
Long QT syndrome 3 1 3 2 2 0 0 1 1 1
Supraventricular tachycardia 2 0 0 0 1 0 0 0 0 2
Atrial flutter 1 1 1 0 0 0 0 0 0 1
Mobitz type I AV block 1 0 0 0 0 0 0 0 0 1
Multifocal atrial tachycardia 1 0 1 0 0 0 0 0 0 1
Premature ventricular contractions 1 0 0 0 0 0 0 0 0 1
Sick sinus syndrome 1 1 1 1 0 0 0 0 0 1
Total 25 4 8 5 5 2 0 1 1 21
DU = drug treatment (in utero); DP = drug treatment (postnatal); P = pacemaker; SHD = structural heart disease; TOP = termination of pregnancy; 
IUD = intrauterine death; NND = neonatal death; Inf/ChD = death in infancy or childhood; A = alive.
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septal defect (n = 1). The most common arrhyth-
mia was premature atrial contractions (44%);
however, all fetuses with this arrhythmia showed
good results.
Mortality was high in long QT syndrome, with
two of the three affected fetuses expiring postna-
tally due to intractable ventricular tachycardia at
4 days of age and suddenly at 10 months despite
β-blocker treatment and pacemaker insertion at
1 month. The sole survivor had an uneventful
postnatal course after initiation of treatment with
potassium channel opener (nicorandil).
Complete AV block was detected in four fe-
tuses. Two pregnancies involving hydrops fetalis
in the second trimester were terminated. Both sur-
vivors had pacemakers implanted neonatally, with
one treated in utero using digoxin. Systemic lupus
erythematosus was detected in two of the four
mothers.
Of the subgroup of non-surviving fetuses where
postmortem examination was not performed, 14
pregnancy terminations and two intrauterine
deaths also involved CHD, while two Down syn-
drome and one AV block did not. Excluding the
above cases, the sensitivity and specificity of fetal
echocardiography for major cardiac defects were
96.6% and 99.1%, respectively. Three CHD fetuses,
with small ventricular septal defect, small aortic
coarctation and critical pulmonary stenosis, were
not detected prenatally. Two neonates with normal
postnatal echocardiography findings had false pre-
natal diagnoses of critical pulmonary stenosis/
pulmonary atresia at 35 weeks’ gestation.
Discussion
In the present study, the most common indica-
tion for fetal echocardiography was abnormal
heart appearance on general fetal ultrasound ex-
amination (36.6%). High incidence (63.7%) of
CHD was noted where the cardiac abnormality
was detected at the general obstetric ultrasound
examination. The four-chamber view of the heart
has been recommended as part of obstetric ultra-
sound evaluation,11 with a high rate of cardiac
malformations noted in cases referred because of
suspicious four-chamber views.4,6
The mean gestational age at CHD diagnosis was
27.8 weeks in our patient series, compared to 27.9,
26 and 26.5/22.7 weeks in studies conducted in
Italy, New York and London (1983/1992), respec-
tively. Further, 35.9% of cardiac malformations
were detected prior to 24 weeks’ gestation in this
study, compared to 43%, 46% and 68%, respec-
tively, in the research above.4,8,12 The higher rate
of early detection in the United Kingdom reflects
an almost universal routine scanning policy in that
country at 17–22 weeks of gestation.1 In Taiwan,
however, although ultrasound scan is used for
most fetuses, cardiac evaluation is not always in-
cluded. It appears reasonable to suggest, there-
fore, that where possible, fetal cardiac evaluation
(four-chamber view of the fetal heart as a mini-
mum) be part of the obstetric scan prior to 24
weeks’ gestation in all pregnancies.
In our study, the proportion of extracardiac/
chromosomal anomalies was 14.6%/28.3%,
whereas the analogous rates were 32%/28%,
19.1%/19.6% and 16%/9% in the Yale, Italian
and New York series, respectively.4,8,12 The lower
incidence of extracardiac anomalies in our study
may reflect the practice of the obstetrician with
respect to terminating a pregnancy with extracar-
diac anomalies without routine referral to the pe-
diatric cardiologist for examining the fetal heart.13
Because of the low rate (51%) of chromosome
analysis in our target population, the correct rate
of chromosome anomalies would be within the
range of 14.6% (15/103) and 28.3% (15/51).
Structural heart defects were detected in only
three (3.4%) of our fetuses with family history of
CHD. The recurrence risk for a subsequent preg-
nancy where a sibling has been diagnosed with
an isolated heart defect in this study was similar
to the general reported incidence (2–4%).14
Heterotaxy syndrome was the most common
type of prenatally detected CHD in our sample
and even in our excluded cases (Tables 2 and 5).
However, ventricular septal defect and tetralogy of
Fallot were the predominant types of postnatally
detected CHD in Taiwan.15 Brick and Allan13 have
stated that the spectrum of prenatally detected
CHD is often different from that seen postnatally.
This may result from the high prenatal detection
rate and larger proportion of prenatal loss in 
severe, complex cardiac anomalies. Further, the
spectrum of prenatally detected CHD in our
study differed from other reports,3,4,6 with 5.8%
of CHD fetuses in London’s Guy’s Hospital also
diagnosed with heterotaxy syndrome,16 com-
pared to 22.3% of our enrolled sample. Although
this proportional difference may reflect the fact
that complex cardiac lesions are more likely to
be detected prenatally and subsequently referred
to medical centers, possible racial difference can-
not be neglected. Gatrad et al17 and Sadiq et al18
also found increased incidence of heterotaxy
syndrome comparing the Asian and English 
population.
Of our 23 fetuses with heterotaxy syndrome,
22 had right atrial isomerism. In contrast, Sharland
and Cook16 reported that left atrial isomerism was
twice as prevalent as the right variant. Gatrad et al
found that the respective ratios of right atrial isom-
erism in heterotaxy syndrome was 60% and 58.5%
for Asian Muslim and English children, respec-
tively.17 Thus, it appears reasonable to speculate
that the high ratio of right atrial isomerism in our
study may also be related to ethnicity.
The outcome for our fetuses with major CHD
(e.g. isomerism, hypoplastic left heart syndrome
and double-outlet right ventricle) remained poor,
except in cases of critical pulmonary stenosis and
pulmonary atresia with intact septum. Analogous
high mortality rates for these CHD variants in other
studies were 80–81%, 55–100% and 25–100%,
respectively.3,4,6,8,13 However, our 0% mortality for
pulmonary stenosis/atresia contrasts markedly
with the relatively higher rate reported elsewhere
(27–46%).3,8,13 Early prostaglandin infusion and
postnatal interventional cardiac catheterization im-
proved the prognosis in our cases of critical pul-
monary stenosis/atresia.19,20 Five of seven fetuses
with prenatally detected ventricular septal defects
also had poor prognosis in this study (Figure 2);
four of these with ventricular septal defects had
concomitant serious extracardiac anomalies, ar-
rhythmia or trisomy. Further, the greater likelihood
that large defects will be diagnosed prenatally may
account for the difference in prognosis compared
to postnatally detected analogues.
In the present study, the overall mortality was
higher where there were associated chromosomal
or extracardiac anomalies (60% and 50%, respec-
tively), with mortality also high in the neonatal
stage. Elevated mortality rates, especially in utero
and in the neonatal stage, with concomitant
chromosomal or extracardiac anomalies have
been reported in several studies.3,4,8
In our sample, fetuses with isolated arrhyth-
mias (except long QT syndrome or hydrops fe-
talis) had good prognosis. The former exception
is frequently associated with familial transmission
and is characterized primarily by prolongation of
the Q-T interval and occurrence of life-threatening
tachyarrhythmias.21 Family history and electro-
cardiography for family members may be help-
ful for prenatal differential diagnosis in fetuses
with unexplained ventricular tachycardia with
AV block.22,23
One false negative and two false positive diag-
noses of pulmonary stenosis/atresia occurred in
fetuses scanned in the third trimester. Poor image
Outcome for fetuses with prenatally detected CHD and cardiac arrhythmias
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Table 5. Excluded fetuses with prenatal diagnosis
of congenital heart defect
Prenatal diagnosis n
Atrial isomerism 16
Double-outlet right ventricle 14
Hypoplastic left heart syndrome 10
Ventricular septal defect 9








Atrioventricular septal defect 2
Other 11
Total 93
quality at late gestational age may have contributed
to these errors. Although cardiac size increases
with fetal age, maternal obesity, fetal lie with spine
in the anterior position, calcified ribs and oligo-
hydramnios at late gestational age will limit the
image quality and make interpretation difficult.24
About 53% of the examined cases were ex-
cluded from the present study, inevitably gener-
ating selection bias in terms of the outcome and
subtype distribution of fetuses with CHD. For ex-
ample, as some of the excluded cases may have
been delivered in local hospitals or clinics where
the quality of care and/or equipment levels may be
somewhat inferior to medical centers, arguably
impacting on prognosis, therefore, their progno-
sis may have been worse compared to those deliv-
ered in medical centers. Thus, taking into account
both the excluded and enrolled fetuses with pre-
natally detected CHD, the outcome may be infe-
rior compared to the studied sample. Although
our investigation was limited in terms of univer-
sal applicability for Taiwan as a whole, this retro-
spective study may provide an important reference
for prenatal consultation, providing information
relevant to prediction of the outcome for prena-
tally detected CHD in Taiwan.
In summary, overall outcome for our sample
of fetuses with CHD detected prenatally in
Taiwan remained poor despite in utero detection.
Complex lesions, and associated extracardiac or
chromosomal anomalies negatively impacted
prognosis. In contrast, prognosis was generally
good for isolated arrhythmias, with the exception
of long QT syndrome and hydrops fetalis. The
abnormally high proportion of heterotaxy syn-
drome and right atrial isomerism in Taiwan may
be due to ethnic variation.
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